Breakthrough £90,000 Alzheimer’s drugs unlikely to benefit patients, report suggests



A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.



Source link : https://www.bbc.com/news/articles/cql77wlqlx7o?at_medium=RSS&at_campaign=rss

Author :

Publish date : 2026-04-16 08:01:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version